Mirador
PrivateLast Round
Series B
1/12/2026
Total Funding Raised
$900M
Momentum Score
25 /100
Company Overview
Mirador Therapeutics is a biotechnology company focused on developing innovative precision therapies for immune-mediated inflammatory and fibrotic diseases, utilizing advanced biology and analytics to promote rapid recovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirador Comps
Public and private peers based on sector, stage, and business model.
Mirador Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | 1/12/2026 | ||||
| Series A | 3/21/2024 |
Mirador Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Farallon Capital Management | Series B, Series A |
| TCG Crossover | Series B, Series A |
| Boxer Capital | Series B, Series A |
| Fairmount Funds Management | Series A, Series B |
| ARCH Venture Partners | Series B, Series A |
| Fidelity Management & Research Company | Series B, Series A |
| Venrock Healthcare Capital Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Certified as a Great Place To Work®.
- Mar 21, 2024
$400M Series A round completed.
Mirador Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mirador's valuation, stock price, and market status.
